Vistin Pharma ASA (VISTN OL) stock market data APIs
kr23.4847
0.09(0.4%)
as of April 4, 2025
Vistin Pharma ASA Financial Data Overview
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Prev. Close
23.3943
Open
23.4847
High
23.4847
Low
23.3734
52 wk Range
20.3109-28.2587
Market Cap
1 047 M
P/E Ratio
16.6197
Shares Outstanding
44 345 K
Revenue
430 M
EPS
0.3735
Dividends (Yield)
0.053
Beta
0.928
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vistin Pharma ASA data using free add-ons & libraries
Get Vistin Pharma ASA Fundamental Data
Vistin Pharma ASA Fundamental data includes:
- Net Revenue: 430 M
- EBITDA: 104 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-10-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vistin Pharma ASA News
New
Vistin Pharma ASA: New CEO appointed
Oslo, Norway, 25th of October 2023 The Board of Directors of Vistin Pharma ASA has appointed Magnus Tolleshaug as the new CEO of Vistin Pharma from 1st of January 2024. Magnus Tolleshaug is currently...
Vistin Pharma ASA: Third quarter 2023 financial results
Oslo, Norway, 25th of October 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter of 2023. Vistin delivers another strong quarter with all...
Vistin Pharma ASA: Invitation to Q3 2023 conference call
Oslo, Norway, 18 October 2023 Vistin Pharma ASA will release its third quarter results on Wednesday 25th of October 2023. Vistin Pharma will host a conference call for all shareholders and intereste...
Vistin Pharma ASA: Mandatory notification of trade
Saga Pure ASA has on 18 September 2023 purchased 100,000 shares in Vistin Pharma ASA at NOK 23,50 per share. After the transaction Saga Pure ASA has a holding of 100,000 shares, corresponding to 0.23...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
